arrow_back Trending Legislation
Share share

Protecting Medical Innovation: Opposing Intellectual Property Waivers

This act aims to protect intellectual property rights in medical innovations, especially those related to COVID-19. It means the U.S. will not support proposals to waive these rights at the World Trade Organization, intending to ensure continued development of new medicines and vaccines. For citizens, this could mean faster access to innovative therapies, but also potentially higher prices for patented drugs.
Key points
Prohibits supporting the waiver of intellectual property rights for COVID-19 medicines and vaccines at the World Trade Organization.
Promotes strong international intellectual property rights to encourage medical innovation.
Protects American investments and medical technology from being taken by other countries.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Preventing Foreign Attempts to Erode Healthcare Innovation Act
Print number: HR 3035
Sponsor: Rep. Donalds, Byron [R-FL-19]
Process start date: 2021-05-07
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Protecting Medical Innovation: Opposing Intellectual Property Waivers

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 3035.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-07.

What are the main provisions?

Key points include:

  • Prohibits supporting the waiver of intellectual property rights for COVID-19 medicines and vaccines at the World Trade Organization.
  • Promotes strong international intellectual property rights to encourage medical innovation.
  • Protects American investments and medical technology from being taken by other countries.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Donalds, Byron [R-FL-19].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Analysis and Potential Impact of HR 3035

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Economy